1. Home
  2. EDSA vs HTCR Comparison

EDSA vs HTCR Comparison

Compare EDSA & HTCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • HTCR
  • Stock Information
  • Founded
  • EDSA 2015
  • HTCR 2009
  • Country
  • EDSA Canada
  • HTCR Japan
  • Employees
  • EDSA N/A
  • HTCR N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • HTCR EDP Services
  • Sector
  • EDSA Health Care
  • HTCR Technology
  • Exchange
  • EDSA Nasdaq
  • HTCR Nasdaq
  • Market Cap
  • EDSA 17.5M
  • HTCR 16.9M
  • IPO Year
  • EDSA N/A
  • HTCR 2022
  • Fundamental
  • Price
  • EDSA $2.72
  • HTCR $0.88
  • Analyst Decision
  • EDSA Strong Buy
  • HTCR
  • Analyst Count
  • EDSA 2
  • HTCR 0
  • Target Price
  • EDSA $13.00
  • HTCR N/A
  • AVG Volume (30 Days)
  • EDSA 121.9K
  • HTCR 304.1K
  • Earning Date
  • EDSA 08-08-2025
  • HTCR 11-13-2025
  • Dividend Yield
  • EDSA N/A
  • HTCR N/A
  • EPS Growth
  • EDSA N/A
  • HTCR N/A
  • EPS
  • EDSA N/A
  • HTCR N/A
  • Revenue
  • EDSA N/A
  • HTCR $29,625,381.00
  • Revenue This Year
  • EDSA N/A
  • HTCR N/A
  • Revenue Next Year
  • EDSA N/A
  • HTCR $3.52
  • P/E Ratio
  • EDSA N/A
  • HTCR N/A
  • Revenue Growth
  • EDSA N/A
  • HTCR 72.95
  • 52 Week Low
  • EDSA $1.55
  • HTCR $0.39
  • 52 Week High
  • EDSA $4.49
  • HTCR $3.38
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 62.87
  • HTCR 46.47
  • Support Level
  • EDSA $2.47
  • HTCR $0.82
  • Resistance Level
  • EDSA $2.82
  • HTCR $0.87
  • Average True Range (ATR)
  • EDSA 0.18
  • HTCR 0.08
  • MACD
  • EDSA 0.03
  • HTCR -0.02
  • Stochastic Oscillator
  • EDSA 85.46
  • HTCR 20.75

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.

Share on Social Networks: